Malignant Ovarian Neoplasm — Trials

Malignant Ovarian Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

3,087 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 685
Recruiting: 386
Ph III recruiting: 46
Growth YoY: +10.6%
Industry share: 36%
Top sponsor: National Cancer Institute (NCI)
Termination share: 32.8%
Trials / 1,000 deaths: 53.2 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (437)

clinicaltrialsPublishedShowing 151–200 of 292 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05969860	At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer	recruiting	Phase 2	220	Mayo ClinicOTHER	1	Apr 20, 2026	clinicaltrials
NCT07340164	Trastzumab Deruxtecan Versus SOC in Recurrent Ovarian That Progressed on Prior PARP Inhibitor Therapy(TROY)	recruiting	Phase 2	116	Yonsei UniversityOTHER	1	Apr 20, 2026	clinicaltrials